What Experts Really Think About Diet Soda
Growing up, Olivia Dreizen Howell, 39, “lived on” diet soda. So did her family. At a family reunion in 1996, everyone sported T-shirts with their shared surname in Diet Coke-can font. “We drank Diet Coke, Diet ginger ale, and Diet Sprite like water—there was no difference in our household,” she says. Like many, Howell believed that sugar-free soda was a benign choice. But the latest research casts doubt on that assumption, linking diet drinks to mood disorders, fatty liver development, autoimmune diseases, and cancer, to name a few.  [time-brightcove not-tgx=”true”] Bef...
Source: TIME: Health - April 9, 2024 Category: Consumer Health News Authors: Perri Ormont Blumberg Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news

Arm Fat Raises CVD Risk in People With Type 2 Diabetes Arm Fat Raises CVD Risk in People With Type 2 Diabetes
In people with type 2 diabetes, cardiovascular disease risk was higher with extra fat on the arms or trunk and lower with extra fat on the legs.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 9, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

Statins Raise Diabetes Risk, but CV Benefit Outweighs It Statins Raise Diabetes Risk, but CV Benefit Outweighs It
Large meta-analysis of individual participant data shows dose-dependent type 2 diabetes increase, but vascular benefit is greater.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 9, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

Chelation Flops for Cardio Health After Heart Attack
(MedPage Today) -- ATLANTA -- Chelation to remove lead and other heavy metals didn't improve outcomes for type 2 diabetes patients after myocardial infarction (MI), the TACT2 trial showed. Cumulative incidence of time to first event (MI, stroke... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - April 8, 2024 Category: Primary Care Source Type: news

Wegovy Helps HFpEF Patients With Diabetes Mellitus
(MedPage Today) -- ATLANTA -- Weight loss and heart failure benefits with semaglutide (Wegovy) extended to patients with obesity-related heart failure with preserved ejection fraction (HFpEF) who have type 2 diabetes, the STEP-HFpEF DM trial showed... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 7, 2024 Category: Cardiology Source Type: news

Specialty Care Access Not Equal Among Teens With Diabetes
(MedPage Today) -- Commercially insured youths with type 2 diabetes were less likely to see specialists compared with their counterparts with type 1 diabetes, a cross-sectional study of claims data indicated. In propensity score-weighted analyses... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 5, 2024 Category: Cardiology Source Type: news

The indulgent eating plan that has helped 250,000 people lose weight
These simple recipes, developed by nutritionists, can help you ditch unwanted pounds, reverse Type 2 diabetes and rewire your eating habits (Source: Daily Express - Health)
Source: Daily Express - Health - April 5, 2024 Category: Consumer Health News Source Type: news

Higher BMI More CVD Protective in Older Adults With T2D? Higher BMI More CVD Protective in Older Adults With T2D?
UK Databank data suggest that the optimal body mass index to prevent cardiovascular death may be higher in older adults with type 2 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 5, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

How Much Exercise Is Advised for Patients With Type 2 Diabetes? How Much Exercise Is Advised for Patients With Type 2 Diabetes?
Engaging in healthy exercise requires a personal medical assessment that identifies the type of training a patient can undertake, said one specialist.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 5, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

EHR-Based Algorithm Does Not Cut Hospitalization in Kidney Dysfunction Triad
THURSDAY, April 4, 2024 -- For patients with the triad of chronic kidney disease, type 2 diabetes, and hypertension, the use of an electronic health record-based algorithm and intervention does not result in reduced hospitalization at one year,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 4, 2024 Category: Pharmaceuticals Source Type: news

Scientists find new 'fat genes' that make you six times more likely to be obese - and up to 10,000 Brits carry them
Researchers at the University of Cambridge also found the genetic quirk was linked with an increased risk of non-alcoholic fatty liver disease and of type 2 diabetes. (Source: the Mail online | Health)
Source: the Mail online | Health - April 4, 2024 Category: Consumer Health News Source Type: news

Primary Care Strategy Fails to Reduce Kidney-Dysfunction Triad Hospitalizations
(MedPage Today) -- Using a personalized algorithm to identify primary care patients with chronic kidney disease (CKD), type 2 diabetes, and hypertension (the kidney-dysfunction triad) -- plus practice facilitators to help providers deliver guideline... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 4, 2024 Category: Cardiology Source Type: news

Basal Insulin Non-Adherence Is Common in Type 2 Diabetes Basal Insulin Non-Adherence Is Common in Type 2 Diabetes
About 44% were non-adherent within 12 months.Medscape UK (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 2, 2024 Category: Consumer Health News Tags: Diabetes & Endocrinology Source Type: news

Scientists link certain gut bacteria to lower heart disease risk
Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease. Now, a team of researchers at the Broad Institute of MIT and Harvard along with Massachusetts General Hospital has found that microbes in the gut may affect cardiovascular disease as well. In a study published in Cell, the team has identified specific species of bacteria that consume cholesterol in the gut and may help lower cholesterol and heart disease risk in people. (Source: World Pharma News)
Source: World Pharma News - April 2, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Here's What OTC Continuous Glucose Monitors Can Do for Our Patients
(MedPage Today) -- About 25 million people stand to gain from the FDA's recent approval of the first over-the-counter continuous glucose monitor (CGM). That means fewer finger pricks and greater access for patients with type 2 diabetes who do not... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 30, 2024 Category: American Health Source Type: news